Guidelines & Statements

Healthy Bones Australia, formerly Osteoporosis Australia, provides the following latest clinical guidelines and position statements which have been developed with Australia’s leading experts and researchers in collaboration with relevant professional associations.

RACGP and Osteoporosis Australia Clinical Guidelines

Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age.

Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age.

Position Statement on the Management of Osteoporosis – FifthEdition

Position Statement on the Management of Osteoporosis February 2023

This Position Statement was first issued following a National Forum in 2019 with leading Australian bone health experts to provide concise and current guidance on common issues requiring clarification for GPs, including:

  • identification;
  • investigation; and
  • treatment options/duration for patients at risk

This fifth edition (February 2023) complements current RACGP Guidelines.

Balancing the risks and benefits of sun exposure: A revised Position Statement for Australian adults

Balancing the risks and benefits of sun exposure: A revised Position Statement for Australian adults, published in Australian and New Zealand journal of Public Health (Feb 2024). This new statement outlines on risks and benefits of sun exposure. It followed a national summit and is endorsed by Royal Australia College of GPs, Australasian College of Dermatologists, Cancer Council Australia, Melanoma Patients Australia, Australian Skin and Skin Cancer research Centre, Healthy Bones Australia, Multiple Sclerosis Australia among others.

Exercise Prescription to Support the Management of Osteoporosis for Physiotherapists and Exercise Physiologists

This new exercise statement was developed by an expert Working Group, Advisory Committee and a National Roundtable and is based on the latest research in the field. In light of the increased skeletal fragility of osteoporosis, it is recommended this exercise prescription be supervised by a clinical exercise physiologist or physiotherapist. Such expertise is required to assess comorbidities and exercise capacity in order to appropriately individualise the exercise prescription. Specificity and overload are required to improve bone mass and strength, and high challenge balance training is required to prevent falls.

Calcium and Vitamin D Position Statement

Position Statement on latest evidence for role of calcium and vitamin D

Position Statement on latest evidence for role of calcium and vitamin D as reviewed by the Bone Health Australia (formerly Osteoporosis Australia) Medical and Scientific Advisory Committee. February 2022.

Exercise and Sports Science Australia Exercise Position Statement

exercise prescription for the prevention and management of osteoporosis

Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis. 2016.